Life sciences firm OptiBiotix Health on Monday entered into an exclusive manufacturing and supply agreement with John Morley Foods for weight management technology SlimBiome.
Life sciences firm Optibiotix Health on Thursday launched a new product in the US that contains its LPLDL cholesterol-reducing and blood pressure-reducing strain.
Life sciences business OptiBiotix Health has entered into a non-exclusive agreement with Seed Health to produce, promote, market, and commercialise products containing 'LP-LDL' in the US, it announced on Tuesday.
OptiBiotix Health has won the award for Weight Management Ingredient of the Year at the Vitafoods European trade show in Geneva, it announced on Friday.
Life sciences firm OptiBiotix Health announced on Tuesday that it will display brand new products and research data at the Vitafoods European tradeshow in Geneva from 15 to 17 May.
(WebFG News) - OptiBiotix Health said on Tuesday that it has signed a non-exclusive UK distribution agreement for its SlimBiome weight management technology with Cambridge Commodities Limited (CCL).
Biotechnology company OptiBiotix Health has appointed Steven Riley as head of its online sales and marketing division.
AIM-quoted life sciences business OptiBiotix has made three new patent filings aimed at protecting the production methods and product application areas arising from its SweetBiotix product development programmes.
UK probiotics specialist OptiBiotix Health said it is moving towards commercialisation with the planned opening of an online store in April.
Food supplements developer Optibiotix has entered into a production and commercialisation agreement with Italian group Fine Foods & Pharmaceuticals, granting the latter with an exclusive license for the production and supply of OptiBiotix's anti-cholesterol probiotic in Europe.
Life sciences business OptiBiotix Health has entered into a manufacturing and supply agreement with Cereal Ingredients, it announced on Tuesday.
Life sciences business OptiBiotix Health issued a product development and commercial update on its 'SlimBiome' product platform on Thursday, reporting that it was launching a new improved version of the platform following the announcement of the manufacturing and supply agreement with Knighton Foods on 1 November.
OptiBiotix Health announced on Tuesday that it had entered a three-year supply agreement with Galenicum Special Ingredients, who would commercialise its products containing its cholesterol and blood pressure reducing strain, LPLDL, across the globe, thus maximising the potential financial returns for both parties.
Life sciences business OptiBiotix Health said it has signed a memorandum of understanding with Bened Biomedical of Taiwan on Wednesday.
Life sciences group OptiBiotix said on Tuesday it had entered into a scale up and manufacturing agreement with Indian soda ash producer, Tata Chemicals.
OptiBiotix said deals with the likes of Tata Chemicals helped it in developing its pro-biotic compounds and put it in a position to fully exploit an expanded range of opportunities in previously unrepresented markets.
Life sciences business OptiBiotix Health announced plans for a US launch of it cholesterol and blood pressure lowering product 'LPLDL' at 'Supply Side West in Las Vegas' on Thursday, to take place on 27 and 28 September.
Life sciences firm OptiBiotix Health granted biotechnology group Sacco SRL an exclusive licence for the manufacture and supply of its cholesterol and blood pressure reducing strain of drugs.
Life sciences compound developer OptiBiotix Health announced on Thursday that it had entered into a three-year supply agreement with HLH BioPharma Vertriebs, covering the supply of its 'LPLDL' capsules.
Life sciences business OptiBiotix Health announced the successful launch of its SlimBiome and LPLDL products at the Vitafoods Europe trade show in Geneva from the 9-11 of May on Tuesday.